Mugglehead Investment Magazine

All posts tagged "Natera"

Biotech operator Personalis sees 10% spike from Medicare covering lung cancer test

Medical and Pharmaceutical

Biotech operator Personalis sees 10% spike from Medicare covering lung cancer blood test

The ctDNA blood draw is known for its ultrasensitive detection capabilities

Rowan DunneFebruary 10, 2026

Medical and Pharmaceutical

Natera and RenaCARE aim for early detection of kidney disease

Natera (NASDAQ:NTRA) acquired full enrolment for the RenaCARE (Renasight Clinical Application, Review and Evaluation) study, which is a prospective, multi-center clinical trial to determine...

Joseph MortonAugust 11, 2022

Medical and Pharmaceutical

The Mugglehead technology roundup: alternative medicine options edition

There are a handful of truisms in terms of alternative medicine. The future of healthcare is often found in the past, and the future...

Joseph MortonJuly 18, 2022

Mugglehead Investment Magazine

All posts tagged "Natera"

Medical and Pharmaceutical

Biotech operator Personalis sees 10% spike from Medicare covering lung cancer blood test

Medical and Pharmaceutical

Natera and RenaCARE aim for early detection of kidney disease

Medical and Pharmaceutical

The Mugglehead technology roundup: alternative medicine options edition

Most Read

AI and Autonomy

Investment firm thinks TOTO is a highly undervalued AI player

AI and Autonomy

Hegseth moves to restrict Anthropic as military expands AI integration

Copper

Glencore bets on Congo copper rebound despite lower annual profit

Cannabis

In Nepal, cannabis becomes an acceptable sacred haze on one special day

Stock News

Financially troubled ‘urban-gro’ soars after acquiring Flash Sports and Media